In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Thomas Cuisset
Speaker
Thomas Cuisset
Thomas Cuisset Thomas Cuisset

Hospital La Timone of Marseille, Marseille (France)

Specialities : Interventional Cardiology , Acute Coronary Syndromes, Interventional Cardiology

10 presentations from this speaker

All patients with atherosclerotic disease should receive long-term intensified antithrombotic treatment beyond aspirin for secondary prevention - CON.

Event : ESC Congress 2019

  • Session : Controversies in antithrombotic treatment for primary and secondary prevention
  • Speaker : T Cuisset (Marseille Cedex 5,FR)

Event prevention.

Event : ESC Congress 2019

  • Session : 2019 ESC Guidelines on Chronic Coronary Syndromes
  • Speaker : T Cuisset (Marseille Cedex 5,FR)

New strategies in STEMI and cardiogenic shock.

Event : ESC Congress 2018

  • Session : 2018 update in interventional cardiology
  • Speaker : T Cuisset (Marseille Cedex 5,FR)
  • European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Prolonged P2Y12 inhibition or Factor Xa inhibition in patients after an acute coronary syndrome

Event : ESC Congress 2018

  • Session : Innovative strategies for secondary prevention
  • Speaker : T Cuisset (Marseille Cedex 5,FR)

Should pharmacotherapy differ?

Event : ESC Congress 2014

  • Session : Bioresorbable scaffolds - disappearing but here to stay?
  • Speaker : T Cuisset (Marseille Cedex 5,FR)

STEMI: essential questions in primary PCI.

Event : ESC Congress 2014

  • Session : Highlights from EuroPCR 2014: main burning questions in interventional cardiovascular interventions
  • Speaker : T Cuisset (Marseille Cedex 5,FR)

Clinical implications of very low on-treatment platelet reactivity in patients treated with thienopyridine: the POBA study (Predictor Of Bleedings with Antiplatelet drugs)

Event : ESC Congress 2013

  • Session : Rapid Fire - Antiplatelet therapies in acute coronary syndromes
  • Speaker : T Cuisset (Marseille Cedex 5,FR)

Panel.

Event : ESC Congress 2013

  • Session : 2013 Great Debate: The burning issues - Bioresorbable scaffolds and dual antiplatelet therapy
  • Speaker : I Al Rashdan (Safat,KW), A Baumbach (London,GB), RA Byrne (Dublin,IE), T Cuisset (Marseille Cedex 5,FR), C Lotan (Jerusalem,IL), CK Naber (Wilhelmshaven,DE)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are